1. Home
  2. LSTA vs CLPS Comparison

LSTA vs CLPS Comparison

Compare LSTA & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • CLPS
  • Stock Information
  • Founded
  • LSTA 1980
  • CLPS 2005
  • Country
  • LSTA United States
  • CLPS Hong Kong
  • Employees
  • LSTA N/A
  • CLPS N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • CLPS Computer Software: Prepackaged Software
  • Sector
  • LSTA Health Care
  • CLPS Technology
  • Exchange
  • LSTA Nasdaq
  • CLPS Nasdaq
  • Market Cap
  • LSTA 31.2M
  • CLPS 35.1M
  • IPO Year
  • LSTA N/A
  • CLPS 2018
  • Fundamental
  • Price
  • LSTA $2.61
  • CLPS $1.25
  • Analyst Decision
  • LSTA Strong Buy
  • CLPS
  • Analyst Count
  • LSTA 1
  • CLPS 0
  • Target Price
  • LSTA $15.00
  • CLPS N/A
  • AVG Volume (30 Days)
  • LSTA 66.3K
  • CLPS 21.4K
  • Earning Date
  • LSTA 02-27-2025
  • CLPS 03-04-2025
  • Dividend Yield
  • LSTA N/A
  • CLPS 9.85%
  • EPS Growth
  • LSTA N/A
  • CLPS N/A
  • EPS
  • LSTA N/A
  • CLPS N/A
  • Revenue
  • LSTA N/A
  • CLPS $142,812,726.00
  • Revenue This Year
  • LSTA N/A
  • CLPS N/A
  • Revenue Next Year
  • LSTA N/A
  • CLPS N/A
  • P/E Ratio
  • LSTA N/A
  • CLPS N/A
  • Revenue Growth
  • LSTA N/A
  • CLPS N/A
  • 52 Week Low
  • LSTA $2.19
  • CLPS $0.68
  • 52 Week High
  • LSTA $4.20
  • CLPS $1.70
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • CLPS 60.32
  • Support Level
  • LSTA $2.45
  • CLPS $1.20
  • Resistance Level
  • LSTA $2.74
  • CLPS $1.28
  • Average True Range (ATR)
  • LSTA 0.32
  • CLPS 0.08
  • MACD
  • LSTA -0.05
  • CLPS 0.00
  • Stochastic Oscillator
  • LSTA 16.48
  • CLPS 78.89

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.

Share on Social Networks: